ArticleNeuroradiology2026
Functional and reperfusion outcomes after mechanical thrombectomy at high altitude: a 32-patient series from Quito, Ecuador.
Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMechanical thrombectomy (MT) is the standard of care for acute ischemic stroke due to large vessel occlusion. In Ecuador, no previous national data on MT outcomes have been reported, and, to our knowledge, there are no published series performed at high altitude.
methodsThis was a retrospective, observational, descriptive study based on consecutive patients treated within a multicenter mechanical thrombectomy program in Quito, Ecuador, located at an altitude of ≈2,800 meters above sea level. Thirty-two patients treated between October 2023 and November 2024 were included. Baseline characteristics, procedural details, and 90-day functional outcomes were analyzed.
resultsThe median age was 64 years [IQR 54-72], and the mean baseline NIHSS score was 18, decreasing to 7 at discharge. The median ASPECTS was 7. Intravenous thrombolysis was administered in 59.4% of patients, and general anesthesia was used in 84.4% of procedures. Successful reperfusion (TICI 2b-3) was achieved in 90.6% of patients, with complete reperfusion (TICI 3) in 62.5%. Neurological complications occurred in 9.4% (all asymptomatic subarachnoid hemorrhages), and 18.8% of patients required decompressive craniectomy (DC). At 90 days, 53.1% achieved functional independence (mRS 0-2).
conclusionsMT at high altitude (≈2,800m) in Ecuador is feasible, safe, and achieves outcomes comparable to international standards. Our study, the first multicenter experience of its kind in Ecuador, highlights a unique physiological risk for patients at this altitude: an elevated risk of cardiac pathologies as etiological factor, and increases susceptibility to severe cerebral edema requiring DC.
Indexed as
Identifiers
42154017What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.